当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 资产负债表

华海药业

(600521)

  

流通市值:189.21亿  总市值:191.24亿
流通股本:14.67亿   总股本:14.83亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,089,955,831.981,924,457,361.331,728,714,585.721,365,152,641.03
应收票据及应收账款2,666,646,717.642,806,605,701.382,628,667,727.012,665,335,476.17
应收账款2,666,646,717.642,806,605,701.382,628,667,727.012,665,335,476.17
应收款项融资65,729,513.44102,914,540.9127,562,555.77166,141,754.12
预付款项88,932,361.6770,048,487.7586,391,260.7472,379,445.61
其他应收款合计28,278,829.0931,705,813.3136,573,451.5847,430,479.44
存货3,519,023,267.043,451,194,741.153,349,190,039.313,374,697,311.7
其他流动资产101,943,548.46325,129,182.05111,423,313.1372,969,379.83
流动资产平衡项目0000
流动资产合计7,646,144,887.828,797,779,617.618,180,537,323.187,907,175,521.63
非流动资产:
长期股权投资402,384,657.08369,819,240.06376,430,613.99387,570,881.96
其他权益工具投资34,913.43,267,913.47,534,913.47,534,913.4
其他非流动金融资产395,373,615.59458,926,514.47474,445,548.62468,068,021.45
投资性房地产6,297,115.756,426,371.366,555,626.976,683,074.33
固定资产4,394,095,163.514,450,920,334.24,509,967,731.854,431,858,698.72
在建工程3,357,949,665.843,211,145,253.682,950,511,592.522,802,561,847.13
使用权资产61,316,317.8265,695,625.3868,870,757.7372,565,583.79
无形资产1,114,729,054.991,132,273,355.61,087,733,518.81,072,247,940.79
开发支出764,611,767.33739,002,540.13739,931,708.25711,503,467.96
商誉70,902,204.1670,902,204.1670,902,204.1670,902,204.16
长期待摊费用29,389,016.2328,111,035.1224,509,580.5726,378,557.05
递延所得税资产187,827,305.58215,204,381.06194,785,393.12183,904,885.45
其他非流动资产365,161.06232,851.411,651,648.412,781,884.36
非流动资产平衡项目0000
非流动资产合计10,785,275,958.3410,751,927,620.0310,513,830,838.3910,244,561,960.55
资产平衡项目0000
资产总计18,431,420,846.1619,549,707,237.6418,694,368,161.5718,151,737,482.18
流动负债:
短期借款1,525,863,333.332,206,332,638.881,685,990,763.891,396,597,666.07
交易性金融负债-14,458,254.31818,661.143,519,394.27
应付票据及应付账款1,349,366,717.051,284,075,940.521,198,287,480.661,202,616,283.42
其中:应付票据525,673,439.55520,043,688403,202,648.8349,947,330.36
应付账款823,693,277.5764,032,252.52795,084,831.86852,668,953.06
合同负债38,629,291.6134,825,011.859,001,502.2867,696,626.32
应付职工薪酬148,854,040.48146,469,301.26147,300,624.82261,978,316.12
应交税费103,360,415.74137,751,633.7205,054,426.06399,449,872.6
其他应付款合计739,685,182.67824,544,496.27704,986,427.6687,727,074.28
一年内到期的非流动负债785,481,252.26921,146,641.26951,960,014.8771,948,772.32
其他流动负债1,343,990.951,213,474.694,742,534.667,020,264.6
流动负债平衡项目0000
流动负债合计4,692,584,224.095,570,817,392.694,958,142,435.914,798,554,270
非流动负债:
长期借款2,770,227,5002,831,584,6003,015,541,3502,888,878,800
应付债券1,812,572,206.451,790,291,956.841,768,252,910.751,746,460,791.54
租赁负债47,983,669.5151,806,403.9454,941,573.259,136,999.33
长期应付款54,600,00053,000,00053,000,00043,000,000
预计负债167,435,609.8170,219,959.1171,985,335.45174,476,743.29
递延收益627,464,612.85623,825,288.53579,134,200.04532,090,355.08
其他非流动负债3,777,7503,777,750163,518,534163,518,534
非流动负债平衡项目0000
非流动负债合计5,484,061,348.615,524,505,958.415,806,373,903.445,607,562,223.24
负债平衡项目0000
负债合计10,176,645,572.711,095,323,351.110,764,516,339.3510,406,116,493.24
所有者权益(或股东权益):
实收资本(或股本)1,482,507,1161,482,507,0871,483,475,0871,483,474,941
其他权益工具240,135,348.49240,135,478.83240,135,478.83240,136,130.51
资本公积1,348,005,409.781,343,773,072.461,338,566,565.321,321,817,769.31
减:库存股355,323,987.89355,323,987.89484,248,196.89484,248,196.89
其他综合收益-1,629,454.88-353,775.5-9,778,812.98-7,519,841.09
专项储备2,927,753.042,937,743.742,152,602.561,364,897.8
盈余公积745,795,769.54745,795,769.54745,795,769.54745,795,769.54
未分配利润4,614,137,180.74,814,644,358.454,418,662,693.574,245,727,768.72
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,076,555,134.788,274,115,746.637,734,761,186.957,546,549,238.9
少数股东权益178,220,138.68180,268,139.91195,090,635.27199,071,750.04
股东权益平衡项目0000
股东权益合计8,254,775,273.468,454,383,886.547,929,851,822.227,745,620,988.94
负债和股东权益合计18,431,420,846.1619,549,707,237.6418,694,368,161.5718,151,737,482.18
公告日期2023-10-312023-08-312023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑